TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
Kunlin Wu(Fujian Medical University), Xiangjin Chen(First Affiliated Hospital of Fujian Medical University)
Cited by 69
Related Papers
Loss of ID3 drives papillary thyroid cancer metastasis by targeting E47-mediated epithelial to mesenchymal transition
|Cell Death Discovery|2021|15
Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer
|Experimental Cell Research|2022|9
Quantitative and correlation analysis of the DNA methylation and expression of DAPK in breast cancer
|PeerJ|2017|8
SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
|Frontiers in Oncology|2023|7